Gene · 3803
Papers1,698
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,698
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic differences between smokers and never-smokers with lung cancer. | Front Immunol | 2023 | 36817482 | PubTator, text mining | PubMed |
| Natural Killer T-like Cells: Immunobiology and Role in Disease. | Int J Mol Sci | 2023 | 36769064 | PubTator, text mining | PubMed |
| Coordinated Loss and Acquisition of NK Cell Surface Markers Accompanied by Generalized Cytokine Dysregulation in COVID-19. | Int J Mol Sci | 2023 | 36768315 | PubTator, text mining | PubMed |
| People with Primary Progressive Multiple Sclerosis Have a Lower Number of Central Memory T Cells and HLA-DR+ Tregs. | Cells | 2023 | 36766781 | PubTator, text mining | PubMed |
| NK cell education: Physiological and pathological influences. | Front Immunol | 2023 | 36742337 | PubTator, text mining | PubMed |
| Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation. | Nat Commun | 2023 | 36737440 | PubTator, text mining | PubMed |
| Innate receptors modulating adaptive T cell responses: KIR-HLA interactions and T cell-mediated control of chronic viral infections. | Immunogenetics | 2023 | 36719466 | PubTator, text mining | PubMed |
| Abnormalities by Multicolor Flow Cytometry for Detection of Minimal Residual Disease in Recipients of Allo-HSCT Originating from Donors: A Cohort Study | Turk J Haematol | 2023 | 36718627 | PubTator, text mining | PubMed |
| The role of the HLA allelic repertoire on the clinical severity of COVID-19 in Canadians, living in the Saskatchewan province. | Hum Immunol | 2023 | 36707385 | PubTator, text mining | PubMed |
| Malaria-driven expansion of adaptive-like functional CD56-negative NK cells correlates with clinical immunity to malaria. | Sci Transl Med | 2023 | 36696483 | PubTator, text mining | PubMed |
| Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia. | Blood Adv | 2023 | 36689727 | PubTator, text mining | PubMed |
| Microarray Profiling of Differentially Expressed Genes in Coronary Artery Bypass Grafts of High-Risk Patients with Postoperative Cognitive Dysfunctions. | Int J Environ Res Public Health | 2023 | 36674212 | PubTator, text mining | PubMed |
| Escape from NK cell tumor surveillance by NGFR-induced lipid remodeling in melanoma. | Sci Adv | 2023 | 36638181 | PubTator, text mining | PubMed |
| KIR Allelic Variation and the Remission of Atopic Dermatitis Over Time. | Immunohorizons | 2023 | 36637513 | PubTator, text mining | PubMed |
| The impact of HLA polymorphism on herpesvirus infection and disease. | Immunogenetics | 2023 | 36595060 | PubTator, text mining | PubMed |
| Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors. | Cancer Commun (Lond) | 2023 | 36585761 | PubTator, text mining | PubMed |
| Software update: Interpreting killer-cell immunoglobulin-like receptors from whole genome sequence data with PING. | HLA | 2023 | 36565030 | PubTator, text mining | PubMed |
| Relationship between KIR genotypes and HLA-ligands with SARS-CoV-2 infection in the Saudi population. | J King Saud Univ Sci | 2023 | 36338940 | PubTator, text mining | PubMed |
| Inhibitory receptors for HLA class I as immune checkpoints for natural killer cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy. | Cancer Immunol Immunother | 2023 | 36261539 | PubTator, text mining | PubMed |
| Local immune recognition of trophoblast in early human pregnancy: controversies and questions. | Nat Rev Immunol | 2023 | 36192648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3803/papers?page=8